Drug Type Small molecule drug |
Synonyms TAK 427, TAK-427 |
Target |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC31H41N5O5 |
InChIKeyFLQQOKYYBPGWEI-UHFFFAOYSA-N |
CAS Registry265671-81-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Atopic | Phase 2 | EU | - | |
Dermatitis, Atopic | Phase 2 | JP | - | |
Rhinitis, Allergic | Phase 2 | EU | - | |
Rhinitis, Allergic | Phase 2 | JP | - | |
Eczema | Preclinical | JP | 01 Dec 2002 |